An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

NCT05226468 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Relapsed AML
Refractory AML

Interventions

DRUG: NEI-01

Sponsor

New Epsilon Innovation Limited